SAMUEL GULKO - Corporate Board Profile

SMITH MICRO SOFTWARE, INC.

Filing Date	Source Excerpt
2010-04-30	Our Board currently has six directors: Thomas G. Campbell, Samuel Gulko, Ted Hoffman, William C. Keiper, William W. Smith, Jr. and Gregory J. Szabo. The class whose term expires at this Annual Meeting contains two directors, Messrs. Gulko and Szabo. The Nominating Committee of the Board of Directors selected, and the Board of Directors approved, Mr. Gulko as nominee for election at the Annual Meeting to the class being elected at this meeting. ... (1) Member of Audit Committee. (2) Member of the Mergers & Acquisitions Committee. ... Mr. Gulko has options to purchase 20,000 shares outstanding as of December 31, 2009. ... The following table sets forth compensation that our directors (other than directors who are named executive officers) earned during 2009 for services as members of our board of directors. ... Samuel Gulko 10,000 39,400 16,127 65,527
2011-04-29	Samuel Gulko (1)(2) 79 Director ... (1) Member of Audit Committee. (2) Member of the Mergers & Acquisitions Committee. ... The following table sets forth compensation that our directors (other than directors who are named executive officers) earned during 2010 for services as members of our board of directors. ... Samuel Gulko 10,000 80,200 14,868 105,068.
2012-04-27	Samuel Gulko (1)(2) 80 Director (1) Member of Audit Committee. (2) Member of the Compensation Committee. Mr. Gulko became a director in October 2004.
2013-04-05	Our Board currently has five directors: Andrew Arno, Thomas G. Campbell, Samuel Gulko, William W. Smith, Jr. and Gregory J. Szabo. The class whose term expires at this Annual Meeting contains two directors, Messrs. Gulko and Arno. The Nominating Committee of the Board of Directors selected, and the Board of Directors approved, Messrs. Gulko and Arno as nominees for election at the Annual Meeting to the class being elected at this meeting. The enclosed proxy will be voted, unless authority is withheld or the proxy is revoked, FOR the election of the nominees named below to hold office until the date of our 2016 Annual Meeting or until their successors have been duly elected and qualified or until they earlier resign, becomes disqualified or disabled, or are otherwise removed. Each returned proxy cannot be voted for a greater number of persons than the nominees named on the proxy. In the unanticipated event that a nominee becomes unable or declines to serve at the time of the Annual Meeting, the proxies will be voted for a substitute person selected by the Nominating Committee of the Board of Directors and approved by the Board of Directors. Messrs. Gulko and Arno have agreed to serve if elected, and management has no reason to believe that they will be unavailable to serve. (1) Member of Audit Committee. (2) Member of the Compensation Committee. Mr. Gulko became a director in October 2004. In addition, since September 2002, he has provided tax and consulting services on a part-time basis to a limited number of clients. From July 1996 until his retirement in September 2002, Mr. Gulko functioned as the Chief Financial Officer, and as the Vice President of Finance, Secretary and Treasurer of Neotherapeutics, Inc., a publicly traded biotechnology company (now known as Spectrum Pharmaceuticals, Inc.). During this same period he also served as a member of the Board of Directors of Neotherapeutics, Inc. From April 1987 to July 1996, Mr. Gulko was self-employed as a Certified Public Accountant and business consultant, as well as the part time Chief Financial Officer of several privately-owned companies. Mr. Gulko was a partner in the audit practice of Ernst & Young LLP, an accounting and business services firm, from September 1968 until March 1987. Mr. Gulko holds a B.S. in Accounting from the University of Southern California. As a senior finance executive, Mr. Gulko brings to our Board extensive qualifications and experience in finance and public accounting, including his prior service as an audit partner at Ernst & Young LLP and as a CFO of a publicly-traded company. The following table sets forth compensation that our directors (other than directors who are named executive officers) earned during 2012 for services as members of our Board of Directors. Andrew Arno $ 10,000 24,100 2,552 36,652 Thomas G. Campbell 10,000 24,100 2,552 36,652 Samuel Gulko 10,000 24,100 2,552 36,652 Gregory J. Szabo 10,000 24,100 2,552 36,652
2014-04-25	Samuel Gulko (1)(2) 82 Director (1) Member of Audit Committee. (2) Member of the Compensation Committee.
2015-04-30	Samuel Gulko (1)(2) 83 Director (1) Member of Audit Committee. (2) Member of the Compensation Committee.
2016-04-29	Our Board currently has six directors: Andrew Arno, Thomas G. Campbell, Steven L. Elfman, Samuel Gulko, William W. Smith, Jr. and Gregory J. Szabo. The class whose term expires at this Annual Meeting contains two directors, Messrs. Arno and Gulko. The Nominating Committee of the Board of Directors selected, and the Board of Directors approved, Messrs. Arno and Gulko as nominees for election at the Annual Meeting to the class being elected at this meeting. The enclosed proxy will be voted, unless authority is withheld or the proxy is revoked, FOR the election of the nominees named below to hold office until the date of our 2019 Annual Meeting or until their successors have been duly elected and qualified or until they earlier resign, becomes disqualified or disabled, or are otherwise removed. Each returned proxy cannot be voted for a greater number of persons than the nominees named on the proxy. In the unanticipated event that a nominee becomes unable or declines to serve at the time of the Annual Meeting, the proxies will be voted for a substitute person selected by the Nominating Committee of the Board of Directors and approved by the Board of Directors. Messrs. Arno and Gulko have agreed to serve if elected, and management has no reason to believe that they will be unavailable to serve. Mr. Gulko became a director in October 2004. In July 2015, Mr. Gulko joined the board of directors and audit committee of Newlead Holdings, Ltd. In addition, since September 2002, he has provided tax and consulting services on a part-time basis to a limited number of clients. From July 1996 until his retirement in September 2002, Mr. Gulko functioned as the Chief Financial Officer, and as the Vice President of Finance, Secretary and Treasurer of Neotherapeutics, Inc., a publicly traded biotechnology company (now known as Spectrum Pharmaceuticals, Inc.). During this same period he also served as a member of the Board of Directors of Neotherapeutics, Inc. From April 1987 to July 1996, Mr. Gulko was self-employed as a Certified Public Accountant and business consultant, as well as the part time Chief Financial Officer of several privately-owned companies. Mr. Gulko was a partner in the audit practice of Ernst & Young LLP, an accounting and business services firm, from September 1968 until March 1987. Mr. Gulko holds a B.S. in Accounting from the University of Southern California. As a senior finance executive, Mr. Gulko brings to our Board extensive qualifications and experience in finance and public accounting, including his prior service as an audit partner at Ernst & Young LLP and as a CFO of a publicly-traded company. Director Compensation for Fiscal 2015 The following table sets forth compensation that our directors (other than directors who are named executive officers) earned during 2015 for services as members of our Board of Directors. Samuel Gulko Fees earned or paid in cash ($) 10,000 StockAwards($) 21,984 OptionAwards($) 0 Total ($) 31,984
2016-07-15	Samuel Gulko is listed as a Named Executive Officer and Director with beneficial ownership of 147,000 shares as of May 31, 2016.
2017-04-28	Continuing Directors for Term Ending at the 2019 Annual Meeting of Stockholders: Name Age Present Position with the Company Samuel Gulko (3)(4) 85 Director (3) Member of Audit Committee (4) Member of the Compensation Committee ... Director Compensation for Fiscal 2016 The following table sets forth compensation that our directors (other than directors who are named executive officers) earned during 2016 for services as members of our Board of Directors. Name Fees earned or paid in cash ($) Stock Awards ($) (1) Option Awards ($) (1) Total ($) Andrew Arno (2) $ 10,000 $ 10,400 $ — $ 20,400 Thomas G. Campbell (3) 10,000 10,400 — 20,400 Steven L. Elfman 10,000 10,400 — 20,400 Samuel Gulko (4) 10,000 10,400 — 20,400 Gregory J. Szabo (5) 10,000 10,400 — 20,400 (1) The amounts shown represent the grant date fair value computed in accordance with FASB ASC Topic 718. The assumptions we used with respect to the valuation of stock and option grants are set forth in Note 8 to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
2019-04-22	Samuel Gulko (2) 87 Director (2) Member of Audit and Compensation Committees Mr. Gulko became a director in October 2004... The following table sets forth compensation that our directors (other than Mr. Smith, who is a named executive officer) earned during 2018 for services as members of our Board of Directors. Samuel Gulko 10,000 Fees earned or paid in cash, 37,000 Stock Awards, Total 47,000.
2020-04-28	Samuel Gulko is a Director, age 88. He serves on the Audit and Compensation Committees. His total director compensation in 2019 was $64,500.
2021-04-28	Continuing Directors with Terms Ending at the 2022 Annual Meeting of Stockholders: Samuel Gulko (2) 89 Director (2) Member of Audit and Compensation Committees ... The following table sets forth compensation that our directors ... Samuel Gulko 20,000 160,000 180,000 ... The amounts shown represent the grant date fair value computed in accordance with FASB ASC Topic 718.
2022-04-27	Samuel Gulko (2) 90 Director (2) Member of Audit and Compensation Committees... The following table sets forth compensation that our directors (other than Mr. Smith, who is a named executive officer and does not separately receive any compensation for his board service) earned during 2021 for services as members of our Board of Directors. Samuel Gulko 20,000 Fees earned or paid in cash, 189,250 Stock Awards, Total 209,250.
2023-04-27	The following table sets forth compensation that our directors (other than Mr. Smith, who is a named executive officer and does not separately receive any compensation for his board service) earned during 2022 for services as members of our Board of Directors. Samuel Gulko 30,000 fees earned in cash, 102,750 stock awards, total 132,750.
2024-03-13	Samuel Gulko is listed as a director. No age, committees, or compensation details are provided.
2024-05-09	(2)Member of Audit and Compensation Committees
2024-10-21	Samuel Gulko listed as a director in the security ownership table